Akèy › Karsinòm selil skuamèz tèt ak kou › South Carolina › Charleston
Etid klinik pou Karsinòm selil skuamèz tèt ak kou nan Charleston, SC
14 etid pou Karsinòm selil skuamèz tèt ak kou ap chèche patisipan nan sit nan ak bò kote Charleston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
Ap rekriteFaz 2/3
- Site#0104, Charleston
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
Ap rekriteFaz 3
- Medical University of South Carolina, Charleston
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
Ap rekriteFaz 2
- Medical University of South Carolina, Charleston
Omission of Postoperative Radiation in HPV-Associated Oropharyngeal Cancer Using ctHPVDNA Surveillance (OPERATION)
Ap rekriteFaz 2
- Medical University of South Carolina, Charleston
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
Ap rekriteFaz 1
- Normunity Investigational Site, Charleston
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
Ap rekriteFaz 2/3
- Medical University of South Carolina, Charleston
Intraoperative Molecular Imaging Using ICG for Head and Neck Tumors
Ap rekriteFaz 2
- Medical University of South Carolina Hollings Cancer Center, Charleston
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
Ap rekriteFaz 3
- GSK Investigational Site, Charleston
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Ap rekriteFaz 2
- USA03-0, Charleston
Risk Adapted De-Intensification of Radio-Chemotherapy for Oropharyngeal Squamous Cell Carcinoma
Ap rekriteFaz 2
- Medical University of South Carolina, Charleston
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
Ap rekriteFaz 3
- Medical University of South Carolina (MUSC), Charleston
Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy
Ap rekrite
- Medical University of South Carolina, Charleston
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Ap rekriteFaz 1/2
- Research Site 123, Charleston
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
Ap rekriteFaz 1
- Medical University of South Carolina, Hollings Cancer Center, Charleston
Etid Karsinòm selil skuamèz tèt ak kou nan lòt vil
- Houston, TX47 etid
- Los Angeles, CA42 etid
- Boston, MA40 etid
- Nashville, TN39 etid
- New York City, NY39 etid
- St. Louis, MO28 etid
- Arlington, VA26 etid
- Philadelphia, PA26 etid
- Chicago, IL26 etid
- Atlanta, GA24 etid
- San Antonio, TX22 etid
- Pittsburgh, PA22 etid
Lòt etid nan Charleston
- Depresyon19 etid
- Akidan serebavaskilè18 etid
- Ensifizyans kadyak18 etid
- Kansè Poumon ki pa ti selil16 etid
- Twoub Estres Post-Traumatik16 etid
- Maladi kadyovaskilè15 etid
- Kansè pwostat15 etid
- Kansè (tout kalite)14 etid
- Maladi Parkinson13 etid
- Maladi poumon entèstisyèl13 etid
- Kansè nan tete12 etid
- Kansè poumon11 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.